II. To conduct a 4 week pilot clinical trial of nicotine-free and flavor-free e-cig use in regular smokeless tobacco (ST) users (n=30), randomized to e-cig use or control (no e-cig use), and assess biomarkers as in Objective 1 by bronchoscopy at baseline and at 4 weeks while on product (week 5 of trial).